期刊文献+

胃肠道间质瘤36例临床分析 被引量:1

胃肠道间质瘤36例临床分析
下载PDF
导出
摘要 目的:探讨胃肠道间质瘤临床特点及诊断与治疗效果。方法:回顾性分析经病理证实的36例胃肠道间质瘤患者的临床和病理资料。结果:36例均行手术治疗,其中良性GIST20例,交界性10例,恶性6例。在30例获随访2~3年的当中,有2例死于肿瘤复发转移,1例术后28个月复发再行手术治疗,其余病例均存活。结论:GIST术前诊断较困难,确诊要依赖于病理学检查。手术是主要的治疗方法,分子靶向治疗也具有辅助意义。 Objective:To summarize the clinical character, diagnosis and treatment of gastrointestinal stromal tumor. Methods:The clinical and pathologic data of 36 GIST patients were retrospectively analyzed, which were treated and pathologically proved by lacteal peaceful of my hospital. Results : Gastrointestinal stromal tumor 36 cases all received operations, in which 20 cases of benign GIST,10 cases of junctional,6 cases of malignant. 30 cases was2 - 3 years of follow-up, in which 2 eases died of tumor recurrenee and metastasis, 1 eases received operation again which relapsed after 28 months. Conclusions: The preoperative diagnosis of GIST is more difficult, and the definite diagnosis of GIST depends on the pathology diagnosis. Radical surgery is the best treatment for GIST, and molecular targeted therapy has a promising assisted effects.
出处 《中国社区医师(医学专业)》 2010年第15期111-112,共2页
关键词 胃肠道间质瘤 诊断 外科治疗 gastrointestinal stromal tumor Diagnosis Surgical treatment
  • 相关文献

参考文献4

二级参考文献30

  • 1沈琳,金懋林.甲磺酸伊马替尼治疗复发或转移性胃肠间质瘤[J].中华肿瘤杂志,2004,26(11):697-699. 被引量:27
  • 2I-ShyanSheen,Kuo-ShyangJeng,Shou-ChuanShih,Chih-RoaKao,Wen-HsingChang,Horng-YuanWang,Po-ChuanWang,Tsang-EnWang,Li-RungShyung,Chih-ZenChen.Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(2):187-192. 被引量:41
  • 3Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol, 1999,23:82-87.
  • 4DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg, 2000,231:51-58.
  • 5Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 2001,438:1-12.
  • 6Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002,33:459-465.
  • 7Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol, 1998,152:1259-1269.
  • 8Taniguchi M, Nishida T, Hirota S, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res, 1999,59:4297-4300.
  • 9Demetri GD. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). Eur J Cancer, 2002,38 Suppl 5:S52-S59.
  • 10Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg, 1992,215:68-77.

共引文献36

同被引文献16

  • 1Zubin MB,Ronald PD.Updates on the management of gastrointestinal stromal tumors[J].Surg Oneol Clin N Am,2012,21(2):301-316.
  • 2Miettinen M,Lasota J.Gastrointestinal stromal tumors--definition ,clinical,histological,immunohistochemical,and molecular genetic features and differential diagnosis[J].Virch Arch,2001,438(1):1-12.
  • 3Bauer S,Rutkowski P, Hohenberger P, et al.Long-term follow- up of patients with GIST undergoing metastasectomy in the era of imatinib-Analysis of prognostic factors (EORTC-STBSG collaborative study)[J].Eur J Surg Oncol,2014,40(4):424-419.
  • 4Miettinen M,Lasota J.Gastrointestinal stromal tumors definition, clinical,histological,immunohistochemical,and molecular genetic features and differential diagnosis[J].Virch Arch,2001,43(8):121-124.
  • 5Mochizuki Y, Kodera Y, Ito S,et al.Treatment and risk factors for recurrence after curative resection of gastrointestinal stromaltumors of the stomaeh[J].World J Gastroenterol,2004,28(9):870-875.
  • 6Bamboat ZM,Dematteo RP.Updates on the management of gastrointestinal stromal tumors[J].Surg Oncol Clin N Am,2012, 21(2):301-316.
  • 7Dematteo RP, Heinrich MC,E1 Rifai WM,et al.Clinical managernentof gastrointestinal stromal tumors: before and after STI-571[J].Hum Pathol, 2002,33(5):466-477.
  • 8DeMatteo RP, Lewis JJ, Leung D,et al.Two hundred gastrointestinal stro-mal tumors: recurrence patterns and prognostic factor for surviva[J].Ann Surg,2000,231(1): 51-58.
  • 9Neuhaus SJ,Clark MA,Hayes AJ,et al.Surgery for gastrointestinal stromal tumour in the post-imatiniberr[J].ANZ Jsrug,2005,75(3): 165-172.
  • 10Gold JS,Dematteo RP.Combined surgical and molecular therapy: the gastrointestinal stromal tumor model[J].Ann Surg,2006,244(2): 176-184.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部